---
trial_id: 1499
discovery_date: 2022-07-23 22:00:47.890896
date: 2022-07-23 22:00:47.890896
title: "A Multi-center, Randomized, Double-blind, Placebo Controlled Study to Investigate the Efficacy and Safety of Ligelizumab (QGE031) in the Treatment of Chronic Inducible Urticaria (CINDU) in Adolescents and Adults Inadequately Controlled With H1-antihi ..."
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct05024058'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
